Literature DB >> 32054244

Increased Risk of Neoplasms in Adult Patients Undergoing Interval Appendectomy.

Jungtak Son1, Yong Jun Park1, Sung Ryol Lee1, Hyung Ook Kim1, Kyung Uk Jung1.   

Abstract

Purpose: The low rate of recurrent appendicitis after initial nonsurgical management of complicated appendicitis supports the recently implemented strategy of omitting routine interval appendectomy. However, several reports have suggested an increased incidence rate of neoplasms in these patients. We aimed to identify the risk of neoplasms in the population undergoing interval appendectomy.
Methods: This study retrospectively analyzed consecutive cases of appendicitis that were treated surgically between January 2014 and December 2018 at a single tertiary referral center. Patients were divided into two groups depending on whether they underwent immediate or interval appendectomy. Demographics and perioperative clinical and pathologic parameters were analyzed.
Results: All 2013 adults included in the study underwent surgical treatment because of an initial diagnosis of acute appendicitis. Of these, 5.5% (111/2013) underwent interval appendectomy. Appendiceal neoplasms were identified on pathologic analysis in 36 (1.8%) cases. The incidence of neoplasm in the interval group was 12.6% (14/111), which was significantly higher than that in the immediate group (1.2%, 22/1902, P < 0.001).
Conclusion: The incidence rate of neoplasms was significantly higher in patients undergoing interval appendectomy. These findings should be considered when choosing treatment options after successful nonsurgical management of complicated appendicitis.

Entities:  

Keywords:  Appendicitis; Complicated appendicitis; Interval appendectomy; Neoplasms

Year:  2020        PMID: 32054244     DOI: 10.3393/ac.2019.10.15.1

Source DB:  PubMed          Journal:  Ann Coloproctol        ISSN: 2287-9714


  1 in total

1.  Benign multicystic mesothelioma of appendiceal origin treated by hyperthermic intraperitoneal chemotherapy: A case report.

Authors:  Suk Jun Lee; Ji Hae Nahm; Jeonghyun Kang; Seung Hyuk Baik; Eun Jung Park
Journal:  Int J Surg Case Rep       Date:  2022-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.